Ethical Dilemma with Stakeholders
You're the CEO of a pharmaceutical company. Your best-selling drug ($2B annual revenue, used by 4 million patients for chronic pain) has…
My north star: We disclose—fast, fully, and on our terms. The “wait for more data” option is a mirage. It exposes the company to criminal liability under FDA adverse-event reporting rules, potential DOJ investigation, securities fraud charges, and derivative litigation that could destroy the firm.Read the full answer
Hour-by-Hour 48-Hour Action Plan (T=0 = 9AM Day 1; Board Meeting = 9AM Day 3 = T=48; Earnings Call = 9AM Day 4 = T=72) Core Guiding Principle: Prioritize patient safety and legal/regulatory compliance (non-negotiable fiduciary and ethical duties) while minimizing unnecessary financial/PR volatility.Read the full answer